Balmedie Pharmacy sold to JMF Healthcare


Share post:

Balmedie Pharmacy based in Aberdeenshire, Scotland has been purchased by local expanding multiple operator JMF Healthcare.

Balmedie Pharmacy is a well-performing community pharmacy that dispenses an average of 5,255 items per month. It lies completely unopposed in the large Aberdeenshire village of Balmedie, which is circa eight miles north of Aberdeen City Centre.

The pharmacy has been owned by Brian Arris since 2004 and was recently brought to market to allow him to pursue other pharmacy business opportunities.

Following a confidential sales process with Christie & Co, JMF Healthcare to benefit from new housing developments in this area of Aberdeenshire such as 300 new homes planned in Balmedie, approved plans for up to 500 new homes in Trump Menie Estate, and 284 new homes planned in Blackdog Village.

Brian Arris, previous owner of Balmedie Pharmacy, comments, “I’m sad to see the business go as the excellent staff have helped grow the pharmacy from scratch since 2004 and we’ve all put our hearts and souls into providing good pharmaceutical care for the village and surrounding area. I’m confident everyone is left in safe hands with John at the helm now.”

John Fowlie, owner of JMF Healthcare Limited, comments, “‘We are delighted to add Balmedie Pharmacy to our group. As a company, we always aim to give our patients a first-class pharmacy service and I am sure this will be the case in Balmedie. I would like to thank Brian for his co-operation in making this acquisition straightforward, and also Karl at Christie & Co for his assistance in the transaction.”

Balmedie Pharmacy was sold for an undisclosed price.



Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...